从分子到医学:通过QSAR分析研究治疗用途的化学实体的进化
Ananya Shukla1, Manjinder Singh1, Paranjeet Kaur1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Current pharmaceutical design
|March 16, 2026
概括
定量结构-活性关系 (QSAR) 建模已经超越了物理有机化学,以帮助药物设计. 这种基于计算机的工具现在可以预测特性,提高药物发现效率,并解决药物化学的未来挑战.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 药物设计和开发 药物设计和开发
背景情况:
- 从历史上看,定量结构-活性关系 (QSAR) 仅限于物理有机化学.
- 现代药物设计需要先进的计算工具,因为越来越复杂和减少错误的需求.
- QSAR建模已经多样化,影响了物理化学性质预测,毒性评估和ADME分析.
研究的目的:
- 提供当代药物化学的概述.
- 突出不同QSAR方法在药物设计中的重要性.
- 讨论QSAR在药物发现中的应用和历史演变.
主要方法:
- 历史和现代量化结构-活动关系 (QSAR) 方法的审查.
- 讨论QSAR在物理化学性质预测,毒性和ADME特性中的应用.
- 分析QSAR在应对强度预测和系列设计等挑战中的作用.
主要成果:
- 从其起源开始,QSAR建模已经显著多样化,在药物设计中提供了广泛的应用.
- 这些方法对于提高效率和减少复杂药物开发过程中的错误至关重要.
- QSAR显示了未来在预测药物效率和优化分子序列方面的进展的前景.
结论:
- 在现代药物设计和开发中,QSAR是不可或缺的计算工具.
- 它的应用涵盖了各种领域,从财产预测到复杂的挑战解决方案.
- 持续开发QSAR方法对于未来的药物发现创新至关重要.
更多相关视频
相关概念视频
Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Drug Discovery: Overview
12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Effects of Chemicals: Overview
2.4K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
2.4K
Quantitative Aspects of Drug-Receptor Interaction
2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K


